EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations

Aline Pasquini Santos iD, Tatiane Carinta de Souza iD, Kaio Evandro Cardoso Aguiar, Ana Caroline Alves da Costa, Natasha Monte, Juliana Carla Gomes Rodrigues, Giovanna Gilioli da Costa Nunes, Rita de Cássia Calderaro Coelho iD, Ândrea Ribeiro-Dos-Santos, André Maurício Ribeiro Dos Santos, Sandro José de Souza, Sidney Emanuel Batista Dos Santos und 3 weitere

American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · 2025

DOI: 10.1002/ajmg.b.33064 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 2025. Verfasst von Aline Pasquini Santos und 14 weiteren Autor:innen. Beteiligte Einrichtung: Research Center of Oncology, Federal University of Pará Belém, Belém, Brazil. Hauptthemen laut MEDLINE: Methylphenidate, Attention Deficit Disorder with Hyperactivity, Indians, South American. Die Arbeit nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In Attention Deficit Hyperactivity Disorder (ADHD), methylphenidate is one of the most widely used drugs, in which patient response significantly impacts prognosis. This study aimed to characterize the molecular profile of 10 genes associated with methylphenidate therapy. Whole‐exome sequencing of 64 indigenous individuals from 12 different indigenous populations in the Amazon was used. A total of 143 genetic variants were identified, of which 123 were analyzed. Among these, three novel and population‐specific variants were found, all with modifying impact, located in the ADGRL3 and ADRA2A genes. In addition, we identified a high‐impact variant in the COMT gene, which exhibited statistical significance in the INDG population compared to other groups, along with five variants with moderate impact and 31 with modifying impact. Our findings highlight the unique genetic profile of indigenous populations in the Brazilian Amazon and provide valuable insights to optimize ADHD management and treatment strategies. This study contributes to improving therapeutic responses to methylphenidate and supports the development of precision medicine guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MethylphenidateAttention Deficit Disorder with HyperactivityIndians, South AmericanHumansBrazilMaleFemaleExome SequencingCatechol O-MethyltransferaseGenetic VariationAdultCentral Nervous System StimulantsPolymorphism, Single NucleotideReceptors, Adrenergic, alpha-2

Stichwörter der Autor:innen

attention deficit disorder with hyperactivityexomegenomicsindigenous peoplesmethylphenidate

Substanzen

MethylphenidateCatechol O-MethyltransferaseCOMT protein, humanADRA2A protein, humanCentral Nervous System StimulantsReceptors, Adrenergic, alpha-2

Autor:innen und Institutionen

  • Research Center of Oncology, Federal University of Pará Belém, Belém, Brazil.
  • Laboratory of Human and Medical Genetics, Institute of Biological Science, Federal University of Pará, Belém, Pará, Brazil.
  • Brain Institute, Federal University of Rio Grande do Norte, Natal, Rio Grande do Norte, Brazil.

ORCID-Profile: Aline Pasquini Santos, Tatiane Carinta de Souza, Rita de Cássia Calderaro Coelho, Marianne Rodrigues Fernandes, Ney Pereira Carneiro Dos Santos

Förderung

  • Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Zitieren

APA

Santos, A. P., de Souza, T. C., Aguiar, K. E. C., da Costa, A. C. A., Monte, N., Rodrigues, J. C. G., Nunes, G. G. D. C., Coelho, R. C. C., Ribeiro-Dos-Santos, Â., Dos Santos, A. M. R., de Souza, S. J., Dos Santos, S. E. B., Burbano, R. M. R., Fernandes, M. R., & Dos Santos, N. P. C. (2025). Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. https://doi.org/10.1002/ajmg.b.33064

Vancouver

Santos AP, de Souza TC, Aguiar KEC, da Costa ACA, Monte N, Rodrigues JCG, et al. Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics. 2025. doi:10.1002/ajmg.b.33064

BibTeX
@article{Santos2025,
  author = {Santos, Aline Pasquini and de Souza, Tatiane Carinta and Aguiar, Kaio Evandro Cardoso and da Costa, Ana Caroline Alves and Monte, Natasha and Rodrigues, Juliana Carla Gomes and Nunes, Giovanna Gilioli da Costa and Coelho, Rita de Cássia Calderaro and Ribeiro-Dos-Santos, Ândrea and Dos Santos, André Maurício Ribeiro and de Souza, Sandro José and Dos Santos, Sidney Emanuel Batista and Burbano, Rommel Mario Rodriguez and Fernandes, Marianne Rodrigues and Dos Santos, Ney Pereira Carneiro},
  title = {Molecular Profiling of Genes Associated With Methylphenidate Pathway Therapy and Discovery of New Variants in Amazonian Amerindian Populations},
  journal = {American Journal of Medical Genetics Part B: Neuropsychiatric Genetics},
  year = {2025},
  doi = {10.1002/ajmg.b.33064}
}
Kostenlos starten →